Answers are grounded in this paper and cite their sources.
Prospective study evaluating urinary NGAL for diagnosing AKI and predicting mortality in chronic liver disease patients, indicating its diagnostic value.
Background urinary neutrophil gelatinase-associated lipocalin (uNGAL) has emerged as a promising biomarker in clinical settings for the differential diagnosis of acute kidney injury (AKI) in chronic liver disease (CLD). This prospective study aims to evaluate the efficiency of uNGAL in the differential diagnosis of AKI among patients with CLD and in predicting short-term mortality in this population.Methods This prospective observational study was conducted from September 2021 to March 2024 at Kasturba Medical College, Manipal, among patients with AKI and CLD. The study was initiated after obtaining institutional ethics committee approval. Demographic and clinical data, including urine samples for NGAL analysis, were collected. Patients were followed for 90 days to record clinical outcomes.Results: Among the 188 CLD patients, 42.6% (N = 80) exhibited prerenal AKI, 41.5% (N = 78) were diagnosed with hepatorenal syndrome (HRS), and 16% (n = 30) were identified as having acute tubular necrosis (ATN). u-NGAL Cutoffs of 631 ng/ml distinguish HRS from ATN [AUC: 0.949, 95% C.I (0.895-1)], with a sensitivity of 92% and specificity of 93%, while 257 ng/ml and 236 ng/ml predict 30-day [AUC: 0.807, 95% C.I (0.740–0.875)] and 90-day [AUC: 0.809, 95% C.I (0.745–0.873)] mortality, respectively. Elevated alanine transaminase (ALT), Model for End-stage Liver Disease-sodium (MELD-Na), and uNGAL levels serve as independent predictors of mortality. Patients with uNGAL >236 ng/ml show higher 90-day mortality, underscoring uNGAL’s diagnostic, and prognostic value in AKI.Conclusion This study shows that uNGAL distinguishes HRS from ATN and serves as a valuable predictor of 30-day and 90-day mortality. Additionally, higher levels of ALT, MELD-Na score, and uNGAL were identified as independent risk factors for mortality.
No takes yet. Share an insight, caveat, or question.
Mohan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: